NCT06966011

Brief Summary

This prospective observational study aims to determine the incidence and clinical impact of rebound pain after peripheral nerve blocks in patients undergoing total knee arthroplasty. Rebound pain is defined as a sudden, severe pain (NRS ≥7) emerging after block resolution. Primary outcome is the incidence of rebound pain; secondary outcomes include pain severity, rescue analgesia use, nausea, vomiting, sleep quality, and patient satisfaction.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 11, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

May 21, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
Last Updated

May 22, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

May 2, 2025

Last Update Submit

May 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Rebound Pain After Peripheral Nerve Block

    Rebound pain is defined as a sudden, severe increase in pain occurring after the resolution of peripheral nerve block, typically within 12-24 hours postoperatively. Pain intensity will be assessed using the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst imaginable pain). A score of NRS ≥7 will be considered as severe pain. Patients will record pain scores in a pain diary, and incidence will be calculated as the proportion of patients meeting the rebound pain criteria.

    Within 48 hours after surgery

Secondary Outcomes (4)

  • Sleep Quality

    From 1 day before surgery to postoperative day 7

  • Patient Satisfaction with Pain Management

    Postoperative day 7 (via telephone follow-up)

  • Total Rescue Analgesic Consumption

    Within 48 hours after surgery

  • Time to First Rescue Analgesia

    Within 48 hours after surgery

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients aged 18 to 70 years who are scheduled for elective unilateral total knee arthroplasty under spinal anesthesia at a tertiary care hospital. All participants will receive peripheral nerve blocks as part of a standardized multimodal analgesia protocol. Patients must be physically and cognitively able to provide consent and complete a postoperative pain diary. Those with contraindications to regional anesthesia, allergies to local anesthetics, or significant comorbidities (ASA IV and above) will be excluded.

You may qualify if:

  • Age between 18 and 70 years
  • ASA physical status I to III
  • Scheduled for elective unilateral total knee arthroplasty under spinal anesthesia
  • Peripheral nerve block (PNB) planned as part of multimodal analgesia
  • Ability to understand and provide written informed consent
  • Willingness and ability to complete the postoperative pain diary

You may not qualify if:

  • Known allergy or hypersensitivity to local anesthetics
  • Contraindication to regional anesthesia
  • ASA physical status IV or higher
  • Neurological or psychiatric disorders interfering with study participation or pain reporting
  • Use of anticoagulants or presence of coagulopathy
  • Use of medications that may alter pain perception or rebound pain response
  • Local infection at the block site
  • Emergency surgeries
  • Inability or unwillingness to complete the postoperative pain diary or follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya City Hospital

Konya, 42090, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Central Study Contacts

Mahmut Tutar, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Anesthesiology and Reanimation

Study Record Dates

First Submitted

May 2, 2025

First Posted

May 11, 2025

Study Start

May 21, 2025

Primary Completion

December 20, 2025

Study Completion

December 25, 2025

Last Updated

May 22, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

This study does not plan to share individual participant data due to institutional policies and patient confidentiality considerations.

Locations